HER2 Support Group Forums
>
Breast Cancer Newsfeed
CuraGen Announces Initiation Of Phase II Trial Of CR011-vcMMAE In Patients With Advan
User Name
Remember Me?
Password
Register
Gallery
FAQ
Members List
Calendar
Search
Today's Posts
Mark Forums Read
Thread Tools
Display Modes
Prev
Next
06-26-2008, 11:14 AM
#
3
runtolive
Senior Member
Join Date: Nov 2007
Posts: 210
chrisy... u r correct... another smart bomb technology by curagen using a toxin from seattle genetics.
eventually both companies drugs from genentech and curagen will both be approved
runtolive
View Public Profile
Send a private message to runtolive
Find More Posts by runtolive
«
Previous Thread
|
Next Thread
»
Thread Tools
Show Printable Version
Email this Page
Display Modes
Switch to Linear Mode
Switch to Hybrid Mode
Threaded Mode
Posting Rules
You
may not
post new threads
You
may not
post replies
You
may not
post attachments
You
may not
edit your posts
BB code
is
On
Smilies
are
On
[IMG]
code is
On
HTML code is
Off
Forum Rules
Forum Jump
User Control Panel
Private Messages
Subscriptions
Who's Online
Search Forums
Forums Home
her2group
Herceptin / Tykerb
Caregivers Corner
Diet and Nutrition
Inflammatory Breast Cancer
Keeping Your Mind Off of BC
Profiles In Courage
My Healthcare Team
Clinical Trials
Articles of Interest
Events and Social Calendar
Breast Cancer Meeting Highlights
General Cancer News
Breast Cancer News
Breast Cancer Newsfeed
All times are GMT -7. The time now is
05:21 AM
.
Threaded Mode